The potential of collagenase as a new therapy for separation of human retained placenta: Hydrolytic potency on human, equine and bovine placentae

Placenta

Volumn 19, Issue 5-6, 1998, Pages 379-383

  Fecteau, K A ^a   Haffner, J C ^a   Eiler, H ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; COLLAGENASE; HYDROXYPROLINE; PROTEIN;

ARTICLE; CATTLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; HORSE; HUMAN; HUMAN TISSUE; HYDROLYSIS; NONHUMAN; PLACENTA; PRIORITY JOURNAL; RETAINED PLACENTA; UMBILICAL ARTERY;

EID: 0031868477     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(98)90077-7     Document Type: Article

References (24)

1. Amenta PS, Gay S, Vaheri A & Martinez-Hernandez A (1986) The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, VI, fibronectin, and laminin in human term placenta. Collag and Rel Res, 6, 125-152.
2. Bakri YN, Rifai A & Legarth J (1993) Placenta previa-percreta: magnetic resonance imaging findings and methotrexate therapy after hysterectomy. Am J Obstet Gynecol, 169, 213-214.
3. Branstreet RB (1965) The Kjeldahl Method for Organic Nitrogen. New York: Academic Press.
4. Brodsky B & Eikenberry EF (1982) Characterization of fibrous forms of collagen. In Methods in Enzymology (Ed.) Cunningham LW & Frederiksen DW pp. 127-174. New York: Academic Press.
5. Carroli G (1991) Management of retained placenta by umbilical vein injection. Br J Obstet Gynaecol, 98, 348-350.
6. Craigo SD & Kapernick PS (1994) Postpartum hemorrhage and the abnormal puerperium. In Current Obstetrics and Gynecologic Diagnosis and Treatment (Ed.) DeCherney AH & Pernoll ML pp. 574-593. Connecticut: Appleton & Lange.
7. Eiler H (1997) Retained placenta. In Current Therapy in Large Animal Theriogenology (Ed.) Youngquist R S pp. 340-348. Philadelphia: W.B. Saunders.
8. Eiler H & Hopkins FM (1992) Bovine retained placenta: Effects of collagenase and hyaluronidase on detachment of placenta. Biol Reprod, 46, 580-585.
9. Eiler H & Hopkins FM (1993) Successful treatment of retained placenta with umbilical cord injections of collagenase in cows. J Am Vet Med Assoc, 203, 436-443.
10. Fecteau KA & Eiler H (1996) Evaluation of injections of collagenase and oxytetracycline via the umbilical artery as treatment for retained placenta in cattle. Am J Vet Res, 57, 522-525.
11. Ginther OJ (1992) Embryology and placentation. In Reproductive Biology of the Mare (Ed.) Ginther, O. J. pp. 345-418. Wisconsin: Equiservices.
12. Haffner JC, Fecteau KA & Eiler H (1997) Equine retained placenta: tolerance to placental injections of bacterial collagenase. Biol Reprod, 56, 140 (abstract).
13. Haffner JC, Fecteau KA, Held JP & Eiler H (1998) Equine retained placenta: technique for and tolerance to umbilical artery injections of collagenase. Theriogenology, 49, 711-716.
14. Han S, Blumenfeld OO & Seifter S (1992) Specific identification of collagens and their fragments by clostridial collagenase and anti-collagenase antibody. Anal Biochem, 201, 336-342.
15. Harris ED & Vater CA (1982) Vertebrate collagenases. In Methods in Enzymology (Ed.) Cunningham LW & Frederiksen DW; pp. 423-452. New York: Academic Press.
16. Huber MG, Wildschut HI, Boer K, Kleiverda G & Hoek FJ (1991) Umbilical vein administration of oxytocin for the management of retained placenta: is it effective? Am J Obstet Gynecol, 164, 1216-1219.
17. Kivirikko KI, Laitinen O & Prockop DJ (1967) Modifications of a specific assay for hydroxyproline in urine. Anal Biochem, 19, 249-255.
18. Komulainen MH, Vayrynen MA, Kauko ML & Saarikoski S (1995) Two cases of placenta accreta managed conservatively. Eur J Obstet, Gynecol Reprod Biol, 62, 135-137.
19. Maj JG & Kankofer M (1997) Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes. Placenta, 18, 683-687.
20. Mookhtiar KA & Van Wart HE (1992) Clostridium histolyticum collagenases: a new look at some old enzymes. Matrix (Suppl. 1), 116-126.
21. O'Brien JM, Barton JR & Donaldson ES (1996) The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol, 175, 1632-1638.
22. Pipingas A, Gulmezoglu AM, Mitri FF & Hofmeyr GJ (1994) Umbilical vein injection for retained placenta: clinical feasibility study of a new technique. East Afr Med J, 71, 396-397.
23. Thomas RL & Blakemore KJ (1990) Evaluation of elevations in maternal serum alpha-fetoprotein: a review. Obstet Gynecol Surv, 45, 269-283.
24. Wilken-Jensen C, Strom V, Nielson MD & Rosenkilde-Gram B (1989) Removing a retained placenta by oxytocin-a controlled study. Am J Obstet Gynecol, 161, 155-156.